uric acid has been researched along with Tinnitus in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Tinnitus: A nonspecific symptom of hearing disorder characterized by the sensation of buzzing, ringing, clicking, pulsations, and other noises in the ear. Objective tinnitus refers to noises generated from within the ear or adjacent structures that can be heard by other individuals. The term subjective tinnitus is used when the sound is audible only to the affected individual. Tinnitus may occur as a manifestation of COCHLEAR DISEASES; VESTIBULOCOCHLEAR NERVE DISEASES; INTRACRANIAL HYPERTENSION; CRANIOCEREBRAL TRAUMA; and other conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Almost half of the patients taking aspirin were unable to tolerate the drug in adequate dosage for six months." | 6.64 | Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. ( Balme, HW; Berry, H; Hart, FD; Huskisson, EC; Scott, J; Wojtulewski, JA, 1974) |
| "Indapamide is an antihypertensive agent similar to thiazides, but with some different effects." | 2.71 | Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. ( Algun, E; Can, S; Ceylan, K; Dogan, E; Erkoc, R; Gonulalan, H; Sayarlioglu, H; Topal, C; Yilmaz, Y, 2005) |
| " Almost half of the patients taking aspirin were unable to tolerate the drug in adequate dosage for six months." | 2.64 | Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin. ( Balme, HW; Berry, H; Hart, FD; Huskisson, EC; Scott, J; Wojtulewski, JA, 1974) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FINKELSTEIN, J | 1 |
| ESCOBAR, E | 1 |
| Ceylan, K | 1 |
| Topal, C | 1 |
| Erkoc, R | 1 |
| Sayarlioglu, H | 1 |
| Can, S | 1 |
| Yilmaz, Y | 1 |
| Dogan, E | 1 |
| Algun, E | 1 |
| Gonulalan, H | 1 |
| Newman, PE | 1 |
| Merrin, C | 1 |
| Huskisson, EC | 1 |
| Wojtulewski, JA | 1 |
| Berry, H | 1 |
| Scott, J | 1 |
| Hart, FD | 1 |
| Balme, HW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of a Cold Water Immersion (CWI) on Pain in People With Gouty Arthritis: A Community Based Randomized Controlled Trial[NCT04587544] | 76 participants (Actual) | Interventional | 2019-07-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for uric acid and Tinnitus
| Article | Year |
|---|---|
Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Calcium; Calcium Metabolism Disorders; Creatinine; D | 2005 |
Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin.
Topics: Acetaminophen; Arthritis, Rheumatoid; Aspirin; Body Temperature; Clinical Trials as Topic; Deafness; | 1974 |
3 other studies available for uric acid and Tinnitus
| Article | Year |
|---|---|
[CONTROLLED SURVEY IN GERIATRICS. II. COMPARATIVE STUDY OF 4 THERAPEUTIC AGENTS].
Topics: Androgens; Blood Chemical Analysis; Cell- and Tissue-Based Therapy; Cholesterol; Estrogens; Fatigue; | 1964 |
Can idiopathic tinnitus be caused by hyperuricemia?
Topics: Humans; Models, Biological; Tinnitus; Uric Acid | 1998 |
Treatment of advanced bladder cancer with cis-diamminedichloroplatinum (II NSC 119875): a pilot study.
Topics: Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Leukopenia; Male; Nausea; Neoplasm Metastas | 1978 |